Woliansky Jonathan, Paddle Paul, Phyland Debra
Department of Otolaryngology-Head and Neck Surgery, 96038Monash Health, Victoria, Australia.
Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Ear Nose Throat J. 2021 Jun;100(5):360-367. doi: 10.1177/0145561319873593. Epub 2019 Sep 23.
In recent years, it has become increasingly apparent that the laryngotracheal stenosis (LTS) cohort comprises distinct etiological subgroups; however, treatment of the disease remains heterogeneous with limited research to date assessing predictors of treatment outcome. We aim to assess clinical and surgical predictors of endoscopic treatment outcome for LTS, as well as to further characterize the disease population. A retrospective chart review of adult patients with LTS presenting over a 16-year period was conducted. Seventy-five patients were identified and subdivided into 4 etiologic subgroups: iatrogenic, idiopathic, autoimmune, and "other" groups. Statistical comparison of iatrogenic and idiopathic groups was performed. Subsequently, stepwise logistic regression was employed to examine the association between clinical/surgical factors and treatment outcome, as measured by tracheostomy incidence and dependence. We demonstrate that patients with iatrogenic LTS were significantly more morbid ( < .001) and had worse disease, with significantly greater percentage stenosis ( = .015) and increased incidence of tracheostomy ( < .001). Analyzing the predictive effect of clinical and surgical variables on endoscopic treatment outcome, we have shown that when adjusted for age, sex, and iatrogenic etiology, patients with an American Society of Anesthesiologist score >2 were significantly more likely to undergo tracheostomy (adjusted odds ratio = 11.23, 95% confidence interval [CI] = 1.47-86.17). Similarly, when compared with their idiopathic counterparts, patients with iatrogenic LTS had higher odds of undergoing tracheostomy (17.33, 95% CI = 1.93-155.66) as were patients with Cotton-Myer grade 3-4 stenosis (9.84, 95% CI = 1.36-71.32). The odds of tracheostomy dependence at time of last follow-up were significantly higher in patients with gastroesophageal reflux disease (15.38, 95% CI = 1.36-174.43) and cerebrovascular accident (9.03, 95% CI = 1.01-81.08), even after adjustment. No surgical techniques were significantly associated with either outcome when adjusted. We present a heterogeneous LTS cohort comprised of homogeneous subgroups with distinct levels of morbidity, disease morphology, and treatment burden. Further our data suggest that the treatment outcome is more dependent on patient factors, rather than surgical technique used.
近年来,越来越明显的是,喉气管狭窄(LTS)人群包含不同的病因亚组;然而,该疾病的治疗仍然存在异质性,迄今为止评估治疗结果预测因素的研究有限。我们旨在评估LTS内镜治疗结果的临床和手术预测因素,并进一步描述该疾病人群。对16年间就诊的成年LTS患者进行了回顾性病历审查。共识别出75例患者,并将其分为4个病因亚组:医源性、特发性、自身免疫性和“其他”组。对医源性和特发性组进行了统计学比较。随后,采用逐步逻辑回归分析临床/手术因素与治疗结果之间的关联,治疗结果通过气管切开发生率和依赖情况来衡量。我们发现,医源性LTS患者的病情明显更严重(P<0.001),疾病更严重,狭窄百分比显著更高(P = 0.015),气管切开发生率更高(P<0.001)。分析临床和手术变量对内镜治疗结果的预测作用,我们发现,在调整年龄、性别和医源性病因后,美国麻醉医师协会评分>2的患者气管切开的可能性显著更高(调整后的优势比 = 11.23,95%置信区间[CI] = 1.47 - 86.17)。同样,与特发性LTS患者相比,医源性LTS患者气管切开的几率更高(17.33,95%CI = 1.93 - 155.66),Cotton-Myer 3 - 4级狭窄患者也是如此(9.84,95%CI = 1.36 - 71.32)。即使在调整后,胃食管反流病患者(15.38,95%CI = 1.36 - 174.43)和脑血管意外患者(9.03,95%CI = 1.01 - 81.08)在最后一次随访时气管切开依赖的几率仍显著更高。调整后,没有手术技术与任何一种结果显著相关。我们展示了一个由具有不同发病程度、疾病形态和治疗负担的同质亚组组成的异质性LTS队列。此外,我们的数据表明,治疗结果更多地取决于患者因素,而非所采用的手术技术。